However, stopping Semaglutide is a safe and common practice that doesn't involve serious health risks
Patent US7790681 - Treatment of cardiac arrhythmias with GLP-1 receptor ligands
Diabetes Care 35:12251231 Russell-Jones D, Cuddihy RM, Hanefeld M et al (2012) Efficacy and safety of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used as monotherapy in drug-naive patients with type 2 diabetes (DURATION-4): a 26-week double-blind study
Redox control of microglial function: molecular mechanisms and functional significance
For instance, according to the latest KFF Health Tracking Poll, approximately 12% of adults report having ever used a GLP-1 agonist, a growing class of prescription medications used for weight loss, diabetes treatment, or to help prevent heart attacks and strokes in adults with heart disease